Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$12.15 USD
+0.40 (3.40%)
Updated Jun 7, 2024 03:59 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 41 - 60 ( 130 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis Returns Sustainable on LT Catalyst Unlocks
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: An Update on Cannabis Capital Raising
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Steady Performance as We Await the Fruits of a Multi-Year Capital Investment Project to Juice Growth
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
2Q23 Steady, Consistent Cash Generation Business, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: 2Q23 U.S. Cannabis Industry Earnings Preview
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Rescheduling Process Recommendation Expected By Year End
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Consumer - Weekly ReHash: Pharma Medical Cannabis Pathway Research Will Pressure DEA
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Cannabis Industry Update: June 2023 Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: States Taking Initiative on 280E Tax Relief Front
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Comparing U.S. Cannabis Cash Flows Tax Adjustments
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: New York''s Revised Regulations the First Step
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Midwestern States Represent The Next Legalization Wave
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Price Deflation a Needed Market Dynamic to Convert Illicit Mkt
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S